EVENT SUMMARY
The AJMC® annual Patient-Centered Oncology Care® (PCOC) conference connects leaders across oncology and value-based care, allowing them to share insights into the rapidly changing cancer care landscape. Our theme, Finding Our Rhythm: Embracing Change in Oncology Care, was addressed in our first panel discussion, In a Wave of Change: Advocacy Is Everyone’s Job, which highlighted the need for oncology professionals at all levels to engage with policymakers.

PCOC Cochair Davey Daniel, MD, of OneOncology led discussions on day one, while Cochair Kathy Oubre, MS, of Pontchartrain Cancer Center testified in Washington, DC; she joined the conference for the second day’s sessions.

For the second year, leaders from cancer care networks and managed service organizations—The US Oncology Network, OneOncology, American Oncology Network, and ONCare Alliance—presented different models for sharing ideas and resources at scale. In addition to popular panels on precision medicine, clinical pathways, and payer perspectives, PCOC 2025 offered new discussions on survivorship and the relationship between primary and oncology care. To learn more, look for our annual PCOC recap issue, which will be published in December 2025.

Technology and AI Are Making Waves

Throughout the conference, experts shared how advances in artificial intelligence (AI), decision support tools, and predictive analytics are helping clinicians reach the right decisions in less time.

But Clinicians Are Still Learning When AI Is Appropriate

Using AI to find clinical trials for patients is very different than using it for clinical pathways—it’s the difference between using AI for what you could do vs what you must do, said David Jackman, MD, of Dana-Farber Cancer Institute.

Handoffs Count Between Primary Care and Oncology

Time and resources should be spent on support staff and navigators who guide patients from a positive screening for cancer to the first visit to an oncologist.

Consolidation Is Driving Care Into Hospitals

Vertical integration is making it harder for independent community oncology practices to compete. As more oncology practices fold into hospital systems, costs will continue to rise, said Sucharu “Chris” Prakash, MD, of Texas Oncology.

Advocacy Can Lead to Access

Leaders from OneOncology shared how joining forces across the organization aided the Center for Cancer and Blood Disorders in its pursuit of a Texas law that will require coverage for CAR T-cell therapy. Said Lisa Sowinski-Raff, PharmD, BCPS, BCOP: “Therapies aren’t innovative unless they can get to patients.”

Everything, Everywhere, All at Once

PCOC concluded with a panel of leaders from the world of pharmaceutical manufacturing. Moderated by Ryan Haumschild, PharmD, MS, MBA, CPEL, the group referenced the news coming from Washington, DC, and elsewhere that could greatly affect the future of the industry. Panelists said there is not one single policy that has the pharma industry concerned; the greater worry is constant upheaval and how policies will interact with each other.

PCOC 2025 BY THE NUMBERS
The following titles were accurate as of the PCOC 2025 event but may have changed since then.
81
Faculty
44
Institutions Represented Among Faculty
15
Multidisciplinary Panel Discussions
35
Articles & Videos Produced by AJMC®
Safiya Abouzaid, PharmD, MPH
Safiya Abouzaid, PharmD, MPH

Johnson & Johnson Vice President, Value, Access, Pricing & Health Care Policy

Suzzette Arnal, PhD
Suzzette Arnal, PhD

Senior Director, Precision Medicine, Genetics, and Lab Services US Oncology Network

Edward ``Ted`` Arrowsmith, MD
Edward ``Ted`` Arrowsmith, MD

Executive Vice President, Therapeutics Tennessee Oncology Medical Director, Pathways OneOncology

Johnetta Blakely, MD, MS, MMHC
Johnetta Blakely, MD, MS, MMHC

Executive VP of Quality and Clinc Operations Tennessee Oncology

Sibel Blau, MD
Sibel Blau, MD

President and CEO, ONCare Alliance, LLC

Anthony Boyd, PharmD
Anthony Boyd, PharmD

Senior Pharmacy Director, Cleveland Clinic

Kristen Boykin, PharmD, BCOP, BCPS
Kristen Boykin, PharmD, BCOP, BCPS

Director of Pharmacy Operations, Florida Cancer Institute and Research Specialists

Les Busby, MD
Les Busby, MD

Chief Medical Officer, US Oncology Network

Melody Chang
Melody Chang

VP of Pharmacy Operations, American Oncology Network

Casey Chiasson
Casey Chiasson

Executive Director, Wilamette Valley Cancer Institute

Davey Daniel, MD
Davey Daniel, MD

Chief Medical Officer, OneOncology

David Eagle, MD
David Eagle, MD

Chair of Legislative Affairs and Patient Advocacy, New York Cancer & Blood Specialists

Josh Eaves
Josh Eaves

Chief Development and Strategy Officer, Florida Cancer Specialists & Research Institute

Mark Fendrick, MD
Mark Fendrick, MD

Director, Center for Value-Based Insurance Design, University of Michigan

Paul Forsberg, PharmD, BCOP, MHA
Paul Forsberg, PharmD, BCOP, MHA

Sr. Director of Pharmacy Solutions, US Oncology Network

Scott Freeswick, PharmD, MS
Scott Freeswick, PharmD, MS

Chief Pharmacy Officer, Memorial Sloan Kettering

Jeremy Friese, MD
Jeremy Friese, MD

Founder & Chief Executive Officer, Humata Health

Danielle Geiger MSN, APRN-NP
Danielle Geiger MSN, APRN-NP

Chief Operating Officer, Nebraska Cancer Specialists

Aimee Ginsburg Chesnick, PharmD, BCPS
Aimee Ginsburg Chesnick, PharmD, BCPS

Director, Clinical Content Strategy, McKesson

Vishnukamal Golla, MD, MPH
Vishnukamal Golla, MD, MPH

VP of Clinical Technology & Performance, Evolent

Ryan Haumschild, PharmD, MS, MBA, CPEL
Ryan Haumschild, PharmD, MS, MBA, CPEL

Vice President of Ambulatory Pharmacy, Emory University and Winship Cancer Institute

Rhonda Henschel, MBA
Rhonda Henschel, MBA

Senior Vice President, Payer and Care Transformation, US Oncology Network

Sophia Humphreys, PharmD, MHA, BCBBS, CPGx
Sophia Humphreys, PharmD, MHA, BCBBS, CPGx

Executive Director of Pharmacy, Providence Health

Jeff Hunnicutt
Jeff Hunnicutt

Chief Executive Officer, Highlands Oncology

Puneeth Indurlal, MD, MS
Puneeth Indurlal, MD, MS

SVP, Strategic Operations, American Oncology Network

David Jackman, MD
David Jackman, MD

Medical Director, Clinical Pathways and New Business Initiatives, Dana-Farber Cancer Institute

David Johnson, MD, MPH
David Johnson, MD, MPH

Chief Physician Executive, Atlas Oncology Partners

Ben Jones
Ben Jones

Vice President, Government Relations and Public Policy, US Oncology Network

Jim Kilgallon, MBA
Jim Kilgallon, MBA

Senior Vice President, U.S. Market Access, Pharmacosmos Therapeutics

Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd
Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd

Executive Vice President and Chief Medical Officer, CLL Society, Inc

James Lee, MS
James Lee, MS

Director of State Regulation & Policy, Community Oncology Alliance (COA)

Aaron Lyss, MBA
Aaron Lyss, MBA

Senior Director Payment and Policy Innovation, OneOncology

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center

Barbara McAneny, MD, FASCO, MACP
Barbara McAneny, MD, FASCO, MACP

Chief Executive Officer, New Mexico Oncology Hematology Consultants Ltd.

Timothy Mok, PharmD, BCOP, BCPS
Timothy Mok, PharmD, BCOP, BCPS

Manager and Assistant Clinical Professor, Kaiser Permanente & UCSF School of Pharmacy

Brian Mulherin, MD
Brian Mulherin, MD

Hematologist-Oncologist, American Oncology Network

Kathy Oubre, MS
Kathy Oubre, MS

Chief Executive Officer, Pontchartrain Cancer Center

Kathryn Paliotta, RN
Kathryn Paliotta, RN

VP Patient Communication, NY Cancer and Blood Specialists

Ray Parzik, MS
Ray Parzik, MS

Payment Innovation Leader & Former Payer VBC Executive Independent, Formerly of Florida Blue, Formerly of The Oncology Institute

Candy Peskey, PharmD, BCPS, BCOP
Candy Peskey, PharmD, BCPS, BCOP

Hematology/Oncology Infusion Center Pharmacist, Mayo Clinic

Jennifer Pichoske, MS, EMBA, AOCNP
Jennifer Pichoske, MS, EMBA, AOCNP

CEO, Hematology Oncology Associates of CNY

Yale Podnos, MD, MPH, FACS
Yale Podnos, MD, MPH, FACS

Chief Medical Officer, The Oncology Institute of Hope & Innovation

Fernanda Polubriaginof, MD, PhD
Fernanda Polubriaginof, MD, PhD

Associate Chief Health Informatics Officer, Memorial Sloan Kettering Cancer Center

Sucharu ``Chris`` Prakash, MD
Sucharu ``Chris`` Prakash, MD

Director Quality Services, Chair Medical Oncology Quality, Medical Director, Texas Oncology

Lisa Raff, PharmD, MSPharm, BCPS, BCOP
Lisa Raff, PharmD, MSPharm, BCPS, BCOP

Vice President of Pharmacy Services, OneOncology

Alti Rahman, MHA, MBA, CSSBB
Alti Rahman, MHA, MBA, CSSBB

Chief Strategy and Innovation Officer, American Oncology Network

Kimberlee Rowett, DNP, MSN, MBA, RN
Kimberlee Rowett, DNP, MSN, MBA, RN

TeleOncology Clinical Manager, Intermountain Health

Barry Russo, MBA
Barry Russo, MBA

CEO, The Center for Cancer and Blood Disorders

Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC

Vice President of Clinical Innovation, American Oncology Network

Alyssa Schatz, DrPH, MSW
Alyssa Schatz, DrPH, MSW

Vice President, Policy and Advocacy, National Comprehensive Cancer Network

Tom Snow, MBA
Tom Snow, MBA

General Manager, US Oncology, Sanofi

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Director, Pharmacy Cancer Care, Mayo Clinic

Stephen Speicher, MD, MS
Stephen Speicher, MD, MS

Senior Medical Director, Head of Healthcare Quality and Patient Safety, Flatiron Health

Tracy Spinks, BBA
Tracy Spinks, BBA

Director Value-based Care, Optum

Stuart Staggs, MSIE
Stuart Staggs, MSIE

Vice President, Transformation and Shared Services, US Oncology Network

Vivek Subbiah, MD
Vivek Subbiah, MD

Chief, Early-Phase Drug Development, Sarah Cancer Research Institute

Steve Swart
Steve Swart

Executive Vice President Practice Operations, American Oncology Network

Jonathan Tinker, MBA, MHA
Jonathan Tinker, MBA, MHA

VP Oncology Services, HCA Healthcare, Sarah Cannon Cancer Network

Emily Touloukian, DO
Emily Touloukian, DO

President and CEO, Coastal Cancer Center

John L. Villano, MD, PhD
John L. Villano, MD, PhD

Director, Clinical Neuro-Oncology, University of Kentucky

Lalan Wilfong, MD
Lalan Wilfong, MD

Senior Vice President, Value Based Care, Thyme Care

Bruce Wilson
Bruce Wilson

VP, US Oncology Care and Access, AstraZeneca

Karen Winkfield, MD, PhD
Karen Winkfield, MD, PhD

Executive Director, Meharry-Vanderbilt Alliance

ATTENDEES REPRESENT LEADING INSTITUTIONS IN VALUE-BASED ONCOLOGY CARE
  • Connecticut Oncology Association/DGH Consulting LLC
  • Oncology PA Solutions
  • McKesson/US Oncology
  • Evolent Health
  • oneoncology
  • Thrive Beyond Coaching
  • American Oncology Network
  • Colla Mental Health
  • Fedora Healthcare Solutions
  • Smirta
  • American Cancer Society
  • AONN+
  • managecare.ai
  • Celltrion
  • Peace Health Sacred Heart – Riverbend Hospital
  • erlanger health
  • erlanger
  • Compass Oncology
  • POHMS/Alliance Cancer
  • Blue Spark Technologies
  • Oncology Health Partners
  • Vanderbilt University Medical Center
  • Thyme Care
  • Tier1 Healthcare Advisors
  • McKesson
  • Tennessee Oncology
  • EXL Health
  • OneOncology
  • mskcc
  • Patient Discovery
  • Reimagine Care
  • Vanderbilt University Medical Center
  • Premier Oncology Hematology Management Society
WHAT YOUR COLLEAGUES ARE READING ON AJMC.COM
Explore the most sought-after PCOC coverage

Information and Integration Can Take Oncology Patients From Surviving to Thriving

In Primary Care–Oncology Collaboration, the Baton Goes Both Ways

Oncology Pharmacists in the Spotlight Amid Rising Drug Costs and Workforce Pressures

Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology

Access Video Interviews from PCOC